Study on the Platelet Factor and β-Thromboglobulin in the Patients with Ischemic Heart Disease

The platelet factor 4 (PF(4) 1. In patients with acute myocardial infarction, the PF(4) and the β-TG levels were significantly higher compared to those of normal controls (P<0.005). 2. In patients with angina pectoris, the PF(4) and the β-TG levels were not signivicantly different from those of n...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Myung Hwan, Huo, Sun Hwae, Kim, Kwon Sam, Kim, Myung Shick, Song, Jung Sang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Association of Internal Medicine 1986
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4534903/
https://www.ncbi.nlm.nih.gov/pubmed/15759368
http://dx.doi.org/10.3904/kjim.1986.1.1.1
Descripción
Sumario:The platelet factor 4 (PF(4) 1. In patients with acute myocardial infarction, the PF(4) and the β-TG levels were significantly higher compared to those of normal controls (P<0.005). 2. In patients with angina pectoris, the PF(4) and the β-TG levels were not signivicantly different from those of normal controls. 3. A pattern of decline in the PF(4) and the β-TG level was shown in patients with acute myocardial infarction by day 10. In conclusion, the measurement of PF(4) and β-TG is a useful method to detect the platect activation in vivo in the patients with ischemic heart disease.

Ejemplares similares